Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

P-glycoprotein (human) monoclonal antibody (MRK16)

 
ALX-801-008-C150 150 µg 1,273.00 USD
Do you need bulk/larger quantities?
 

Product Details

Alternative Name:ABCB1, CD243, P-glycoprotein 1
 
Clone:MRK16
 
Host:Mouse
 
Isotype:IgG2a
 
Immunogen:Adriamycin-resistant human myelogenous leukemia K-562/ADM cells.
 
UniProt ID:P08183
 
Species reactivity:Human
 
Specificity:Recognizes an external epitope of human P-glycoprotein. Also recognizes P-glycoprotein of human cortical adenomas.
 
Crossreactivity:Does not cross-react with mouse P-glycoprotein.
 
Applications:Flow Cytometry, IHC (FS), IP, FUNC
 
Recommended Dilutions/Conditions:Flow Cytometry: For 5x105 pelleted cells use 50µl of 10-100µg/ml.
Immunohistochemistry (frozen sections): 0.1-10µg/ml. Use mild fixation treatment such as 4% paraformaldehyde. Do not use acetone, paraffin, methanol or ethanol as a fixative. Iodine labelling can also be performed on MRK16.
Immunoprecipitation: 25-50µg/ml
Suggested dilutions/conditions may not be available for all applications. Optimal conditions must be determined individually for each application.
 
Application Notes:Functional Application: Inhibits P-glycoprotein function.
Not recommended for Western blot (epitope recognized by this antibody may be lost in the presence of protein denaturing agents such as SDS).
 
Purity Detail:Protein A affinity purified.
 
Formulation:Liquid. In PBS containing 1% BSA and 0.1% sodium azide.
 
Handling:Avoid freeze/thaw cycles.
 
Shipping:Blue Ice
 
Long Term Storage:-20°C
 
Regulatory Status:RUO - Research Use Only
 

Product Literature References

Conformational heterogeneity of P-glycoprotein: K. Goda, et al.; Cancer Detect. Prev. 24, 415 (2000), Abstract;
Functional characterization of glycosylation-deficient human P-glycoprotein using a vaccinia virus expression system: J.J. Gribar, et al.; J. Membr. Biol. 173, 203 (2000), Abstract;
Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein: F. Ushigome, et al.; Eur. J. Pharmacol. 408, 1 (2000), Abstract;
Modulation of multidrug resistance in human leukemia cells with mdr1-targeted antisense oligonucleotides using variable treatment schedules: H. Dassow, et al.; Int. J. Clin. Pharmacol. Ther. 38, 209 (2000), Abstract;
Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier: V.V. Rao, et al.; PNAS 96, 3900 (1999), Abstract; Full Text
Discordance of P-glycoprotein expression and function in acute leukemia: B. De Moerloose, et al.; Adv. Exp. Med. Biol. 457, 107 (1999), Abstract;
P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833: M. Egashira, et al.; Blood 93, 599 (1999), Abstract; Full Text
Reference method for detection of Pgp mediated multidrug resistance in human hematological malignancies: a method validated by the laboratories of the French Drug Resistance Network: S. Huet, et al.; Cytometry 34, 248 (1998), Abstract;
The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis: M.J. Smyth, et al.; PNAS 95, 7024 (1998), Abstract; Full Text
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations: W.T. Beck, et al.; Cancer Res. 56, 3010 (1996), Abstract;
In vivo imaging and specific targeting of P-glycoprotein expression in multidrug resistant nude mice xenografts with [125I]MRK-16 monoclonal antibody: A.M. Scott, et al.; Nucl. Med. Biol. 22, 497 (1995), Abstract;
Cystic fibrosis-type mutational analysis in the ATP-binding cassette transporter signature of human P-glycoprotein MDR1: T. Hoof, et al.; J. Biol. Chem. 269, 20575 (1994), Abstract; Full Text
Binding properties of monoclonal antibodies recognizing external epitopes of the human MDR1 P-glycoprotein: A.H. Schinkel, et al.; Int. J. Cancer 55, 478 (1993), Abstract;
Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators: J. Hunter, et al.; J. Biol. Chem. 268, 14991 (1993), Abstract; Full Text
Specific targeting and killing activities of anti-P-glycoprotein monoclonal antibody MRK16 directed against intrinsically multidrug-resistant human colorectal carcinoma cell lines in the nude mouse model: T. Iwahashi, et al.; Cancer Res. 53, 5475 (1993), Abstract;
Topology of P-glycoprotein as determined by epitope mapping of MRK-16 monoclonal antibody: E. Georges, et al.; J. Biol. Chem. 268, 1792 (1993), Abstract; Full Text
Decreased P-glycoprotein expression in multidrug-sensitive and -resistant human myeloma cells induced by the cytokine leukoregulin: C.H. Evans & P.D. Baker; Cancer Res. 52, 5893 (1992), Abstract;
Detection of multidrug-resistant protein, P-glycoprotein in childhood leukaemia and lymphoma: Y. Mizuno, et al.; Eur. J. Pediatr. 150, 416 (1991), Abstract;
Immunohistochemical detection of multidrug resistance associated P-glycoprotein in tumour and stromal cells of human cancers: D. Schlaifer, et al.; Br. J. Cancer 62, 177 (1990), Abstract;
Further characterization of the human adrenal-derived P-glycoprotein recognized by monoclonal antibody MRK 16 reacting with only human P-glycoprotein: I. Sugawara, et al.; Jpn. J. Cancer Res. 80, 1199 (1989), Abstract;
Multidrug resistance in cultured human leukemia and lymphoma cell lines detected by a monoclonal antibody, MRK16: Y. Ishida, et al.; Jpn. J. Cancer Res. 80, 1006 (1989), Abstract;
Mechanisms of multidrug resistance and implications for therapy: T. Tsuruo; Jpn. J. Cancer Res. 79, 285 (1988), Abstract;
A monoclonal antibody-Pseudomonas toxin conjugate that specifically kills multidrug-resistant cells: D.J. FitzGerald, et al.; PNAS 84, 4288 (1987), Abstract;
Functional role for the 170- to 180-kDa glycoprotein specific to drug- resistant tumor cells as revealed by monoclonal antibodies: H. Hamada and T. Tsuruo; PNAS 83, 7785 (1986), Abstract;

Product Toolbox

PRODUCT RESOURCES

Datasheet
SDS
Certificate of Analysis

RELATED PRODUCTS

By target:
P-glycoprotein
By biological activity:
P-glycoprotein Monoclonal antibody
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service